⌘K

Login Start Free

Home/Filings/4/0001415889-24-005672

4//SEC Filing

Walsh Angela 4

Accession 0001415889-24-005672

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 12:51 PM ET

Size

5.4 KB

Accession

0001415889-24-005672

Insider Transaction Report

Form 4

Period: 2024-02-26

Virios Therapeutics, Inc.VIRI

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2024-02-26+63,618→ 63,618 total
Exercise: $0.36Exp: 2034-02-26→ Common Stock (63,618 underlying)

Footnotes (1)

[F1]The stock option will vest 100% on February 26, 2025, one year following the grant date.

Documents

1 file

4
form4-02282024_050228.xmlPrimary

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825987

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 12:51 PM ET
Size: 5.4 KB

View on SEC.gov